Literature DB >> 31179105

Novel risk model for predicting acute adverse drug reactions following cardiac catheterization from TRUST study (The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization).

Yibo He1, Yuming Huang1,2, Junqing Yang1, Jin Liu1, Guoli Sun1, Feier Song1, Shiqun Chen1,2, Ning Tan1, Zhonghan Ni1, Yong Liu1, Jiyan Chen1.   

Abstract

BACKGROUND: Acute drug reactions (ADRs) are common complications of contrast administration following cardiac catheterization. Serious reactions may be life threatening. However, few risk models for predicting ADRs exist. The study aims to develop a novel tool for predicting the risk of ADRs [occurring within 1 hour in patients undergoing coronary angiography or percutaneous coronary intervention (PCI)].
METHODS: A total of 17,139 consecutive patients included in the TRUST study were randomly (2:1) assigned to a development data set (n=11,426) or a validation data set (n=5,713). Multivariate logistic regression was applied to identify independent predictors of contrast-induced nephropathy (CIN), including age, contrast dose, premedication, and prehydration. The performance of our model was assessed using the c-statistic for discrimination and the Hosmer-Lemeshow test for calibration.
RESULTS: The overall incidence of ADRs was 42 (0.37%) in the development data set: 0.09% in the low-risk category (score: 0-2), 0.36% in the moderate-risk category (score: 3-4), and 1.78% in the high-risk category (score ≥5). The risk score across the subgroup of the study population exhibited good discrimination and predictive ability for ADRs (c-statistic: 0.694). Meanwhile, the calibration was also demonstrated to be accurate by the Hosmer-Lemeshow goodness-of-fit test (P=0.305).
CONCLUSIONS: Our data showed that our simple risk model showed good discrimination and predictive ability of ADRs following cardiac catheterization.

Entities:  

Keywords:  Adverse drug reactions (ADRs); contrast media; coronary angiography; percutaneous coronary intervention (PCI); risk assessment; risk prediction

Year:  2019        PMID: 31179105      PMCID: PMC6531703          DOI: 10.21037/jtd.2019.04.66

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  18 in total

1.  Management of acute adverse reactions to contrast media.

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-01-23       Impact factor: 5.315

Review 2.  Review article: Acute serious and fatal reactions to contrast media: our current understanding.

Authors:  S K Morcos
Journal:  Br J Radiol       Date:  2005-08       Impact factor: 3.039

3.  Safety of iobitridol in the general population and at-risk patients.

Authors:  Thomas J Vogl; Elmar Honold; Michael Wolf; H Mohajeri; R Hammerstingl
Journal:  Eur Radiol       Date:  2006-01-21       Impact factor: 5.315

Review 4.  Prevention of generalized reactions to contrast media: a consensus report and guidelines.

Authors:  S K Morcos; H S Thomsen; J A Webb
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

5.  Hospital-acquired renal insufficiency.

Authors:  Kevin Nash; Abdul Hafeez; Susan Hou
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

6.  Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization.

Authors:  A G C Sutton; P Finn; P G Campbell; D J A Price; J A Hall; M J Stewart; A Davies; N J Linker; M A De Belder
Journal:  J Invasive Cardiol       Date:  2003-03       Impact factor: 2.022

7.  Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk of adverse reaction to intravascular contrast agents.

Authors:  S Radhakrishnan; S Manoharan; M Fleet
Journal:  Clin Radiol       Date:  2005-01       Impact factor: 2.350

8.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

9.  Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.

Authors:  A F Kopp; K J Mortele; Y D Cho; P Palkowitsch; M A Bettmann; C D Claussen
Journal:  Acta Radiol       Date:  2008-10       Impact factor: 1.990

10.  ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.

Authors:  Manesh R Patel; Gregory J Dehmer; John W Hirshfeld; Peter K Smith; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2009-02-10       Impact factor: 24.094

View more
  5 in total

1.  Predicting acute adverse contrast mean reactions following cardiac catheterization: a complex undertaking.

Authors:  Marco Di Maio; Davide Capodanno
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

2.  Acute adverse drug reactions following cardiac catheterization: evidence-based guidance for providers and systems.

Authors:  Spencer W Trooboff; Alexander Iribarne
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

3.  Acute adverse drug reactions with contrast media after cardiac catheterization: can we identify those at risk?

Authors:  Dhruv Mahtta; Ankur Jain; Islam Y Elgendy
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

4.  Risk of Hypersensitivity Reactions to Iopromide After Intra-Arterial Versus Intravenous Administration: A Nested Case-Control Analysis of 133,331 Patients.

Authors:  Jan Endrikat; Alexander Michel; Ralf Kölbach; Philipp Lengsfeld; Kai Vogtländer
Journal:  Invest Radiol       Date:  2020-01       Impact factor: 10.065

5.  Clinical characteristics and management of iodine contrast media-related anaphylactic shock during cardiac catheterization.

Authors:  Zhiwei Huang; Hongliang Zhang; Yong Wang; Weixian Yang; Shubin Qiao; Fenghuan Hu
Journal:  World Allergy Organ J       Date:  2020-09-08       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.